Investors purchased shares of Becton, Dickinson and Company (NYSE:BDX) on weakness during trading hours on Tuesday. $65.73 million flowed into the stock on the tick-up and $41.01 million flowed out of the stock on the tick-down, for a money net flow of $24.72 million into the stock. Of all equities tracked, Becton, Dickinson and had the 8th highest net in-flow for the day. Becton, Dickinson and traded down ($2.56) for the day and closed at $193.73

BDX has been the subject of several analyst reports. BidaskClub cut shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Piper Jaffray Companies reissued a “buy” rating and set a $213.00 price target on shares of Becton, Dickinson and in a report on Tuesday, September 12th. Bank of America Corporation reaffirmed a “buy” rating and issued a $225.00 target price (up from $200.00) on shares of Becton, Dickinson and in a report on Friday, July 21st. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday, August 9th. Finally, Zacks Investment Research cut shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Monday, August 7th. Five equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $200.93.

The firm has a 50-day moving average price of $197.37 and a 200 day moving average price of $192.32. The firm has a market capitalization of $44.37 billion, a price-to-earnings ratio of 56.47 and a beta of 1.05.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The business had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.06 billion. During the same period in the previous year, the firm earned $2.35 EPS. The business’s revenue for the quarter was down 5.1% on a year-over-year basis. Equities analysts predict that Becton, Dickinson and Company will post $9.46 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 29th. Investors of record on Friday, September 8th were issued a $0.73 dividend. The ex-dividend date was Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.50%. Becton, Dickinson and’s payout ratio is currently 83.43%.

In related news, insider Gary M. Cohen sold 15,512 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $203.77, for a total value of $3,160,880.24. Following the sale, the insider now directly owns 95,781 shares in the company, valued at approximately $19,517,294.37. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Stephen Sichak sold 11,787 shares of the business’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $200.46, for a total transaction of $2,362,822.02. Following the completion of the sale, the insider now owns 14,038 shares in the company, valued at $2,814,057.48. The disclosure for this sale can be found here. Insiders sold a total of 75,904 shares of company stock worth $15,242,688 over the last quarter. Insiders own 1.40% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Almanack Investment Partners LLC. bought a new stake in shares of Becton, Dickinson and in the 1st quarter worth approximately $105,000. Parkside Financial Bank & Trust raised its holdings in shares of Becton, Dickinson and by 1.4% in the 1st quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock worth $116,000 after purchasing an additional 9 shares in the last quarter. QCI Asset Management Inc. NY raised its holdings in shares of Becton, Dickinson and by 9.2% in the 1st quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock worth $130,000 after purchasing an additional 60 shares in the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of Becton, Dickinson and by 55.8% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock worth $131,000 after purchasing an additional 240 shares in the last quarter. Finally, Harfst & Associates Inc. raised its holdings in shares of Becton, Dickinson and by 46.4% in the 2nd quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock worth $135,000 after purchasing an additional 221 shares in the last quarter. Institutional investors and hedge funds own 87.12% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Marea Informative and is owned by of Marea Informative. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at http://www.mareainformativa.com/traders-buy-shares-of-becton-dickinson-and-company-bdx-on-weakness/116950/.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Receive News & Stock Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related stocks with our FREE daily email newsletter.